EAM Investors’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-235,813
Closed -$4.04M 250
2024
Q4
$4.04M Sell
235,813
-36,821
-14% -$693K 0.57% 82
2024
Q3
$5.45M Sell
272,634
-102,343
-27% -$1.59M 0.81% 19
2024
Q2
$4.19M Sell
374,977
-247,109
-40% -$2.07M 0.68% 44
2024
Q1
$4.11M Buy
+622,086
New +$3.4M 0.64% 56
2023
Q4
Sell
-967,146
Closed -$3.46M 237
2023
Q3
$3.46M Buy
967,146
+83,304
+9% +$321K 0.67% 21
2023
Q2
$3.26M Sell
883,842
-151,910
-15% -$563K 0.6% 35
2023
Q1
$3.43M Sell
1,035,752
-713,846
-41% -$2.47M 0.67% 21
2022
Q4
$6.79M Buy
1,749,598
+322,438
+23% +$995K 1.41% 1
2022
Q3
$3.47M Buy
1,427,160
+179,024
+14% +$429K 0.75% 16
2022
Q2
$2.47M Buy
+1,248,136
New +$2.46M 0.6% 41

Other funds holding ADMA